- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Shilpa Medicare has announced a board meeting to approve the financial results for the quarter and half-year. Consolidated revenue rose to ₹1,309.57 Cr from ₹1,159.77 Cr last year, while consolidated profit after tax jumped to ₹78.29 Cr versus ₹31.87 Cr, overcoming exceptional charges of ₹28.08 Cr linked to legal settlements and impairments. The board approved a final dividend of Re. 1 per share, pending shareholder nod. New appointments include VV.J. Talati & Co as Cost Auditors and BDO India LLP as Internal Auditors for FY26. Shilpa Biologicals Pvt Ltd is now designated a material subsidiary.